Investors Count
1Funding, Valuation & Revenue
2 Fundings
Karos Pharmaceuticals's latest funding round was a Series B for on August 17, 2016.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
8/17/2016 | Series B | 1 | ||||
7/7/2010 | Series A |
Date | 8/17/2016 | 7/7/2010 |
---|---|---|
Round | Series B | Series A |
Amount | ||
Investors | ||
Valuation | ||
Revenue | ||
Sources | 1 |
Karos Pharmaceuticals Investors
1 Investors
Karos Pharmaceuticals has 1 investors. New Leaf Venture Partners invested in Karos Pharmaceuticals's Series B funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
---|---|---|---|---|---|---|
8/17/2016 | 8/17/2016 | 1 Series B | Venture Capital | New York |
First funding | 8/17/2016 |
---|---|
Last Funding | 8/17/2016 |
Investor | |
Rounds | 1 Series B |
Board Seats | |
Type | Venture Capital |
Location | New York |
Loading...